Smartphone-enabled 3D printing of medicines

被引:47
作者
Xu, Xiaoyan [1 ]
Seijo-Rabina, Alejandro [2 ,3 ]
Awad, Atheer [1 ]
Rial, Carlos [4 ]
Gaisford, Simon [1 ,4 ]
Basit, Abdul W. [1 ,4 ]
Goyanes, Alvaro [1 ,2 ,3 ,4 ]
机构
[1] UCL, UCL Sch Pharm, Dept Pharmaceut, 29-39 Brunswick Sq, London WC1N 1AX, England
[2] Univ Santiago de Compostela, Fac Farm, ID Farma GI 1645, Dept Farmacol Farm & Tecnol Farmceut, Santiago De Compostela 15782, Spain
[3] Univ Santiago de Compostela, Hlth Res Inst Santiago de Compostela IDIS, Santiago De Compostela 15782, Spain
[4] FabRx Ltd, 7B North Lane, Canterbury CT2 7EB, Kent, England
关键词
Three-dimensional printing of drug products; Additive Manufacturing of formulations and; drug delivery systems; Personalized Medicines; Digital Healthcare and Industry 4; 0; Printing Pharmaceuticals; Vat photopolymerization; WARFARIN THERAPY; EOSIN-Y; RELEASE; DISSOLUTION; BICARBONATE; DEPOSITION; BEHAVIOR;
D O I
10.1016/j.ijpharm.2021.121199
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
3D printing is a manufacturing technique that is transforming numerous industrial sectors, particularly where it is key tool in the development and fabrication of medicinees that are personalised to the individual needs of patients. Most 3D printers are relatively large, require trained operators and must be located in a pharmaceutical setting to manufacture dosage forms. In order to realise fully the potential of point-of-care manufacturing of medicines, portable printers that are easy to operate are required. Here, we report the development of a 3D printer that operates using a mobile smartphone. The printer, operating on stereolithographic principles, uses the light from the smartphone's screen to photopolymerise liquid resins and create solid structures. The shape of the printed dosage form is determined using a custom app on the smartphone. Warfarin-loaded Printlets (3D printed tablets) of various sizes and patient-centred shapes (caplet, triangle, diamond, square, pentagon, torus, and gyroid lattices) were successfully printed to a high resolution and with excellent dimensional precision using different photosensitive resins. The drug was present in an amorphous form, and the Printlets displayed sustained release characterises. The promising proof-of-concept results support the future potential of this compact, userfriendly and interconnected smartphone-based system for point-of-care manufacturing of personalised medications.
引用
收藏
页数:11
相关论文
共 83 条
[1]   Engineering precision biomaterials for personalized medicine [J].
Aguado, Brian A. ;
Grim, Joseph C. ;
Rosales, Adrianne M. ;
Watson-Capps, Jana J. ;
Anseth, Kristi S. .
SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (424)
[2]  
Ahmad Iqbal, 2013, ISRN Pharm, V2013, P958712, DOI 10.1155/2013/958712
[3]   Rapid High-Resolution Visible Light 3D Printing [J].
Ahn, Dowon ;
Stevens, Lynn M. ;
Zhou, Kevin ;
Page, Zachariah A. .
ACS CENTRAL SCIENCE, 2020, 6 (09) :1555-1563
[4]   Industry 4.0 for pharmaceutical manufacturing: Preparing for the smart factories of the future [J].
Arden, N. Sarah ;
Fisher, Adam C. ;
Tyner, Katherine ;
Yu, Lawrence X. ;
Lee, Sau L. ;
Kopcha, Michael .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 602
[5]   Connected healthcare: Improving patient care using digital health technologies [J].
Awad, Atheer ;
Trenfield, Sarah J. ;
Pollard, Thomas D. ;
Ong, Jun Jie ;
Elbadawi, Moe ;
McCoubrey, Laura E. ;
Goyanes, Alvaro ;
Gaisford, Simon ;
Basit, Abdul W. .
ADVANCED DRUG DELIVERY REVIEWS, 2021, 178
[6]  
BNF, 2021, WARF SOD
[7]   3D printing for chemical, pharmaceutical and biological applications [J].
Capel, Andrew J. ;
Rimington, Rowan P. ;
Lewis, Mark P. ;
Christie, Steven D. R. .
NATURE REVIEWS CHEMISTRY, 2018, 2 (12) :422-436
[8]  
Caudill C, 2021, P NATL ACAD SCI USA, V118, DOI [10.1073/pnas.2102595118|1of8, 10.1073/pnas.2102595118]
[9]   Spatially controlled coating of continuous liquid interface production microneedles for transdermal protein delivery [J].
Caudill, Cassie L. ;
Perry, Jillian L. ;
Tian, Shaomin ;
Luft, J. Christopher ;
DeSimone, Joseph M. .
JOURNAL OF CONTROLLED RELEASE, 2018, 284 :122-132
[10]  
Elbadawi M., 2021, ADV DRUG DELIVER REV, V175, DOI DOI 10.1016/j.addr.2021.05.015